# Red Violet, Inc.: overview RDVT · Nasdaq · CIK 1720116 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/rdvt.md) · [Financials](/companies/rdvt/financials.md) · [Filings](/companies/rdvt/filings.md) · [Insiders](/companies/rdvt/insiders.md) Latest reported revenue: [$26.7m](/filings/0001193125-26-342598.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 10, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-342598). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [19.1](/filings/0001193125-25-267173.md) | [19.6 d](/filings/0001193125-26-091708.md) | [22.0](/filings/0001193125-26-209274.md) | [21.8](/filings/0001193125-26-342598.md) | [23.1](/filings/0001193125-25-267173.md) | [23.4 d](/filings/0001193125-26-091708.md) | [25.8](/filings/0001193125-26-209274.md) | [26.7](/filings/0001193125-26-342598.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [13.1%](/filings/0001193125-25-267173.md) | [1.9% d](/filings/0001193125-26-091708.md) | [19.1%](/filings/0001193125-26-209274.md) | [12.6%](/filings/0001193125-26-342598.md) | [19.8%](/filings/0001193125-25-267173.md) | [6.8% d](/filings/0001193125-26-091708.md) | [21.1%](/filings/0001193125-26-209274.md) | [22.8%](/filings/0001193125-26-342598.md) | | Net margin | % | [9.0%](/filings/0001193125-25-267173.md) | [4.4% d](/filings/0001193125-26-091708.md) | [15.6%](/filings/0001193125-26-209274.md) | [12.3%](/filings/0001193125-26-342598.md) | [18.3%](/filings/0001193125-25-267173.md) | [12.0% d](/filings/0001193125-26-091708.md) | [17.0%](/filings/0001193125-26-209274.md) | [18.6%](/filings/0001193125-26-342598.md) | | Diluted EPS | $ per share | [0.12](/filings/0001193125-25-267173.md) | not reported | [0.24](/filings/0001193125-26-209274.md) | [0.18](/filings/0001193125-26-342598.md) | [0.29](/filings/0001193125-25-267173.md) | not reported | [0.30](/filings/0001193125-26-209274.md) | [0.34](/filings/0001193125-26-342598.md) | | Free cash flow | $m | [7.2 d](/filings/0001193125-25-267173.md) | [6.7 d](/filings/0001193125-26-091708.md) | [5.0](/filings/0001193125-26-209274.md) | [7.3 d](/filings/0001193125-26-342598.md) | [10.0 d](/filings/0001193125-25-267173.md) | [6.6 d](/filings/0001193125-26-091708.md) | [6.5](/filings/0001193125-26-209274.md) | [10.5 d](/filings/0001193125-26-342598.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [44.0](/filings/0000950170-23-006736.md) | [53.3](/filings/0000950170-24-028115.md) | [60.2](/filings/0000950170-25-029184.md) | [75.2](/filings/0001193125-26-091708.md) | [90.3](/filings/0001193125-26-091708.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(3.0%)](/filings/0000950170-23-006736.md) | [0.7%](/filings/0000950170-24-028115.md) | [4.2%](/filings/0000950170-25-029184.md) | [10.5%](/filings/0001193125-26-091708.md) | [14.6%](/filings/0001193125-26-091708.md) | | Net margin | % | [1.5%](/filings/0000950170-23-006736.md) | [1.2%](/filings/0000950170-24-028115.md) | [22.5%](/filings/0000950170-25-029184.md) | [9.3%](/filings/0001193125-26-091708.md) | [14.6%](/filings/0001193125-26-091708.md) | | Diluted EPS | $ per share | [0.05](/filings/0000950170-23-006736.md) | [0.04](/filings/0000950170-24-028115.md) | [0.96](/filings/0000950170-25-029184.md) | [0.50](/filings/0001193125-26-091708.md) | [0.91](/filings/0001193125-26-091708.md) | | Free cash flow | $m | [8.7](/filings/0000950170-23-006736.md) | [12.1](/filings/0000950170-24-028115.md) | [14.9](/filings/0000950170-25-029184.md) | [23.8](/filings/0001193125-26-091708.md) | [28.8](/filings/0001193125-26-091708.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/rdvt/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $60.6m | 950,761 | | Added +40,373 | | [WASATCH ADVISORS LP](/funds/814133.md) | 2026-06-30 | $56.8m | 890,738 | | Reduced −20,898 | | [Trigran Investments, Inc.](/funds/1336800.md) | 2026-06-30 | $38.2m | 600,169 | | Reduced −5,987 | | [ASHFORD CAPITAL MANAGEMENT INC](/funds/897070.md) | 2026-06-30 | $36.7m | 575,194 | | Reduced −111,622 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $33.3m | 522,775 | | Added +10,770 | | [Ophir Asset Management Pty Ltd](/funds/1844640.md) | 2026-06-30 | $32.4m | 509,187 | | Reduced −161,235 | | [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $23.0m | 360,661 | | Added +15,400 | | [ROYAL BANK OF CANADA](/funds/1000275.md) | 2026-06-30 | $21.6m | 339,445 | | Added +108,358 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $20.3m | 318,908 | | Added +14,720 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $18.5m | 290,373 | | Reduced −15,868 | ## Recent filings [All 440 filings](/companies/rdvt/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-11 | 17:26 ET | [8-K](/filings/0001193125-26-345050.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-345050 | | 2026-08-10 | 16:55 ET | [10-Q](/filings/0001193125-26-342598.md) | Quarterly report, period 2026-06-30 | 0001193125-26-342598 | | 2026-08-07 | 16:20 ET | [8-K](/filings/0001193125-26-340311.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-340311 | | 2026-08-05 | 16:05 ET | [8-K](/filings/0001193125-26-335043.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-335043 | | 2026-06-05 | 16:59 ET | [8-K](/filings/0001193125-26-259851.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-26-259851 | | 2026-06-01 | 19:47 ET | [SCHEDULE 13D/A](/filings/0001193125-26-252050.md) | Ownership report, active investor, amended | 0001193125-26-252050 | | 2026-06-01 | 19:27 ET | [SCHEDULE 13D](/filings/0001193125-26-252011.md) | Ownership report, active investor | 0001193125-26-252011 | | 2026-05-07 | 16:20 ET | [8-K](/filings/0001193125-26-212022.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-212022 | | 2026-05-06 | 16:55 ET | [10-Q](/filings/0001193125-26-209274.md) | Quarterly report, period 2026-03-31 | 0001193125-26-209274 | | 2026-04-21 | 16:44 ET | [DEF 14A](/filings/0001193125-26-167043.md) | Proxy statement, period 2026-04-20 | 0001193125-26-167043 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-091708.md), filed Mar 4, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/4d069d98-9e1b-47e2-897f-96b0c7efbe49) ## About the filer - CIK: 1720116 - Tickers: RDVT - Exchange: Nasdaq - SIC code: 7372 Services-Prepackaged Software - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.